Liposomal daunorubicin

Liposomal daunorubicin is a chemotherapy drug that is FDA approved to treat AIDS-related Kaposi's sarcoma. It is also commonly used to treat specific types of leukaemia and non-Hodgkin lymphoma. Liposomal daunorubicin is intravenously administered. It utilizes the liposomal carrier system that provides a favorable pharmacokinetic profile at the site of KS lesions...
Read article at Wikipedia
Edit and Show details

Add or delete facts, expose empty fields, download data in JSON or RDF formats, and explore topic metadata.

Freebase Logo
What is Freebase?

Freebase is a huge collection of facts, built by people like you. Freebase connects facts in ways other sites can't, giving you new ways to explore millions of subjects.
You can help improve it!

Flag this Topic
Why do you want to flag this topic?
Freebase Attribution

Freebase data is free for use under the CC-BY license.

The original description for this topic was automatically generated from the Wikipedia article "Liposomal daunorubicin" licensed under the GNU Free Documentation License .
Learn more about Freebase licensing and attribution